DEFA14A
Neratinib Improves PFS in HER2+ Metastatic Breast Cancer
Local Executive Pay Experiences Recovery - Los Angeles Business Journal
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Alan Auerbach - Berkeley Law
PBYI: Puma Biotechnology Inc Stock Price Quote - NASDAQ GS - Bloomberg
Alan Auerbach: Puma Biotech's Overnight Billionaire - Forbes India
Robbins Geller Rudman & Dowd LLP Announces Plaintiff's Verdict in Securities Class Action Trial Against Puma Biotechnology, Inc. and Its Ceo, Alan H. Auerbach
Barry Simon vs Alan Auerbach | Comparably
Puma Biotechnology Executive Salaries | Comparably
Puma Biotechnology CEO And Leadership: Executives and Demographics - Zippia
Puma Biotechnology - Contacts, Employees, Board Members, Advisors & Alumni
Shareholders to Recover $55 Million in Rare Jury Verdict
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Part 2: Alan Auerbach President & CEO Puma Biotech - YouTube
Alan AUERBACH | CEO | Puma Biotechnology, Inc, California | Corporate | Research profile
Puma Biotechnology, Inc. - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer
Puma Biotechnology Culture | Comparably
Alan Auerbach email address & phone number | Puma Biotechnology, Inc Chief Executive Officer, President contact information - RocketReach
Puma FY 2020_Proxy
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
Biotech Entrepreneur's Fortune Nearly Doubles After Strong Clinical Trials For Cancer Treatment
JP Morgan Healthcare, Day 3: Puma Biotechnology, Natera | Precision Oncology News
Alan Auerbach
